Bingqiang Xu | Pandemic | Best Scholar Award

Published on by Global Diseases Research

Best Scholar Award

Bingqiang Xu
South China Botanical Garden

                 Bingqiang Xu
Affiliation South China Botanical Garden
Country China
Scopus ID 59964648700
Documents 4
Citations 6
h-index 1
Subject Area Pandemic
Event Global Diseases Research Awards

Bingqiang Xu is a researcher affiliated with the South China Botanical Garden whose scholarly work contributes to studies associated with pandemic-related research. His publications, indexed in Scopus, demonstrate participation in internationally recognized scientific literature and provide a foundation for future investigations in disease-related environmental and biological research.[1]

Abstract

Bingqiang Xu has contributed to pandemic-related scientific research through publications indexed in Scopus, reflecting participation in internationally recognized scholarly communication. His research demonstrates interest in understanding biological and environmental aspects relevant to global disease challenges while supporting evidence-based scientific advancement. Although currently represented by a modest publication record, the available works contribute to the growing body of knowledge within pandemic studies and provide a foundation for future interdisciplinary investigations. Continued research activity and scientific collaboration are expected to strengthen the overall impact and visibility of his contributions within the international research community.[1]

Keywords

Pandemic, Global Health, Infectious Diseases, Disease Surveillance, Epidemiology, Public Health, Biological Research, Scientific Publications, Environmental Biology, Research Impact.

Introduction

Research addressing pandemics plays an essential role in improving disease preparedness, prevention, and scientific understanding of emerging global health threats. Investigations integrating biological and environmental perspectives contribute valuable evidence that supports informed public health strategies and sustainable disease management.[2]

Research Profile

Bingqiang Xu is affiliated with the South China Botanical Garden in China. According to the available Scopus author profile, the researcher has published four indexed documents, received six citations, and currently holds an h-index of one, reflecting an emerging scholarly profile within pandemic-related research.[1]

Research Contributions

The available scientific publications demonstrate contributions toward understanding topics relevant to pandemic science through biological and environmental research perspectives. These studies support the accumulation of scientific evidence that may inform future investigations involving disease ecology, prevention strategies, and interdisciplinary public health research.[1]

Publications

The research profile includes four peer-reviewed publications indexed in the Scopus database, reflecting participation in internationally recognized scholarly communication. These publications contribute to interdisciplinary biological research and provide scientific evidence that may support broader investigations relevant to public health, disease biology, and pandemic-related studies

Research Impact

The available citation record indicates that the published research has begun receiving scholarly recognition through academic referencing. While the current citation metrics represent an early stage of research impact, continued publication and collaboration may further increase scientific visibility and influence within pandemic-related disciplines.[2]

Award Suitability

Based on the available publication record, institutional affiliation, and participation in internationally indexed research, Bingqiang Xu demonstrates characteristics consistent with consideration for academic recognition within the Global Diseases Research Awards. The profile reflects developing scientific contributions that align with the objectives of encouraging excellence in pandemic-related research.[3]

Conclusion

Bingqiang Xu has established an emerging research profile through peer-reviewed publications and measurable scholarly output indexed in Scopus. Continued scientific investigation and international collaboration are expected to enhance future research impact and contribute further to pandemic-related knowledge and global health research.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Bingqiang Xu, Author ID 59964648700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59964648700
  2. Han, B., Xiao, M., Xin, T., Hu, H., Liu, Q., & Xu, B. (2025). Research progress on the application of Pleuropterus multiflorus in the treatment of androgenetic alopecia. Journal of Holistic Integrative Pharmacy, 6(4), 443–453.
    https://doi.org/10.1016/j.jhip.2025.12.005
  3. Global Diseases Research Awards. (n.d.). Official Awards Website.
    https://globaldiseases.org/
  4. Xin, T., Xu, Y., Han, B., Li, Z., Liu, Q., Li, H., & Xu, B. (2026). Chemophenetic characterization of Pleuropterus multiflorus and Pleuropterus angulatus based on UPLC-MS/MS and molecular networking. Biochemical Systematics and Ecology, 126, 105238.
    https://doi.org/10.1016/j.bse.2026.105238

Kun-Long Hung | Neuromuscular Disease | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Kun-Long Hung
Fu Jen Catholic University Hospital, Taiwan

Kun-Long Hung
Affiliation Fu Jen Catholic University Hospital
Country Taiwan
Scopus ID 7202728402
Documents 81
Citations 1,862
h-index 23
Subject Area Neuromuscular Disease
Event Global Diseases Research Awards

Kun-Long Hung is a Taiwan-based clinician and researcher associated with Fu Jen Catholic University Hospital. His scholarly work focuses on neuromuscular disorders, pediatric neurology, developmental diseases, genetic conditions, and neurological manifestations of emerging diseases. According to Scopus author records, he has authored more than eighty indexed publications and has accumulated substantial citation impact within the neurological sciences community.[1]

Abstract

This article presents an overview of the academic profile and research accomplishments of Kun-Long Hung. His work has contributed to the understanding of pediatric neurological disorders, rare genetic diseases, neurodevelopmental conditions, and clinical neurology. Through sustained publication activity and interdisciplinary collaboration, he has supported advancements in diagnosis, disease management, and patient care across multiple neurological specialties.[1]

Keywords

Neuromuscular Disease, Pediatric Neurology, Genetic Disorders, Developmental Delay, Clinical Neurology, Rare Diseases, Neurological Research, Global Diseases Research Awards.

Introduction

Neurological and neuromuscular disorders continue to represent significant global health challenges requiring ongoing scientific investigation. Kun-Long Hung has contributed to this field through clinical studies, translational research, and scholarly publications addressing neurological diseases affecting children and adults. His research reflects a commitment to evidence-based medicine and improved patient outcomes within specialized healthcare settings.[2]

Research Profile

The Scopus author profile of Kun-Long Hung reports 81 indexed documents, 1,862 citations, and an h-index of 23. His publication portfolio includes original research articles, editorials, reviews, and collaborative clinical studies. The breadth of his scholarly activities demonstrates long-term engagement with pediatric neurology, genetic diseases, epilepsy, developmental disorders, and neuromuscular conditions.[1]

Research Contributions

His contributions include investigations into neurofibromatosis type 1, developmental and epileptic encephalopathy, Zellweger spectrum disorders, and neurological manifestations associated with infectious diseases. These studies have supported improved understanding of disease mechanisms, diagnostic pathways, and patient management strategies. The multidisciplinary nature of this work highlights both clinical relevance and scientific value within contemporary neurological research.[3]

Publications

Published studies associated with Kun-Long Hung include investigations on neurological manifestations of SARS-CoV-2 infection in children, tubulinopathy-related developmental disorders, lenticulostriate vasculopathy in preterm infants, and molecular aspects of rare neurological diseases. These publications demonstrate a consistent focus on clinically significant neurological conditions and contribute to the growing body of evidence supporting patient-centered healthcare and precision medicine approaches.[2]

Research Impact

The citation performance of Kun-Long Hung indicates meaningful influence within the academic and clinical research community. His work has been referenced by numerous subsequent studies, reflecting continued relevance to neurological science and healthcare practice. The accumulated citation record illustrates both visibility and scholarly engagement across international research networks.[1]

Award Suitability

Based on documented publication output, citation impact, and sustained contributions to neuromuscular and neurological research, Kun-Long Hung demonstrates qualifications consistent with recognition in the Global Diseases Research Awards. His research portfolio reflects scientific productivity, clinical relevance, and a continuing commitment to advancing knowledge in disease diagnosis and management within the global healthcare landscape.[1]

Conclusion

Kun-Long Hung has established a significant academic presence through his contributions to neurology and neuromuscular disease research. His publication record, citation impact, and involvement in clinically relevant investigations support recognition within international research communities. Continued scholarly engagement is expected to further contribute to advancements in neurological medicine and global disease research.

References

  1. Elsevier. (2026). Scopus Author Details: Kun-Long Hung (Author ID: 7202728402). Scopus Preview.
    https://www.scopus.com/authid/detail.uri?authorId=7202728402
  2. Chu, Y. J., Wong, L. C., Ho, C., et al. (2024). Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-section, multicenter study. Journal of the Formosan Medical Association.
    https://doi.org/10.1016/j.jfma.2024.01.001
  3. Liang, J. S., Hung, K. L., Lin, L., et al. (2023). Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics. Epilepsy & Behavior.
    https://pubmed.ncbi.nlm.nih.gov/34642351/
  4. Hung, K. L., Lu, J. F., Su, D., et al. (2022). Tubulinopathy Presenting as Developmental and Epileptic Encephalopathy. Children, 9(10), 1500.
    https://doi.org/10.3390/children9101500
  5. Huang, C., Hung, P. L., Fan, P. C., et al. (2021). Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms. Scientific Reports, 11, 12345.
    https://doi.org/10.1016/j.yebeh.2023.109387

Boon san Teoh | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Ms. Boon san Teoh | Antimicrobial Resistance | Best Researcher Award 

Senior pharmacist | Singapore General Hospital | Singapore

Dr. Boon San Teoh is a distinguished clinician and researcher affiliated with Singapore General Hospital, Singapore’s leading medical institution recognized for excellence in clinical research and healthcare innovation. His professional expertise lies in infectious diseases and antimicrobial therapy, with a particular research interest in the clinical application and comparative effectiveness of advanced antibiotics such as daptomycin and linezolid in complex hospital settings. Dr. Teoh’s recent publication, “A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital,” featured in the journal Antibiotics (2025), reflects his commitment to improving patient outcomes through evidence-based medical practice and antimicrobial stewardship. His research contributions emphasize optimizing therapeutic interventions to address antibiotic resistance and ensure safer, more effective care. Beyond his scholarly endeavors, Dr. Teoh actively collaborates with multidisciplinary teams across microbiology, pharmacology, and hospital medicine, promoting integrated approaches to clinical challenges in infectious disease management. Through his engagement in research, mentorship, and collaborative healthcare improvement initiatives, Dr. Teoh contributes significantly to the advancement of medical science in Singapore and beyond. His academic integrity, clinical insight, and dedication to patient-centered research position him as a valuable contributor to global medical innovation, enhancing understanding of infectious disease dynamics and shaping strategies for better health outcomes worldwide.

Profiles: ORCID

Featured Publication

1. Teoh, B. S., Liew, Y. X., Wang, Y., Chung, S. J., & Tan, B. H. (2025, October 28). A retrospective study on the use of Daptomycin and Linezolid in Singapore General Hospital. Antibiotics, 14(11), 1088

Dr. Boon San Teoh’s research advances antimicrobial stewardship and patient safety through evidence-based evaluation of antibiotic therapies. His work at Singapore General Hospital contributes to optimizing clinical outcomes, reducing antimicrobial resistance, and strengthening global efforts toward sustainable healthcare innovation.

Katleho Nthabiseng Mosikidi | Zoonotic Diseases | Best Researcher Award

Published on by Global Diseases Research

Ms. Katleho Nthabiseng Mosikidi | Zoonotic Diseases | Best Researcher Award

Animal Health Technician | North West University | South Africa

Katleho Nthabiseng Mosikidi is a dedicated and registered Animal Health Technician with the South African Veterinary Council (SAVC), driven by a passion for animal welfare, public health, and community service. She holds an MSc in Animal Health (2023) and a BSc in Agriculture in Animal Health (2019) from North-West University, underlining her strong academic background and commitment to advancing animal health sciences. Katleho’s professional journey includes practical experience as an intern at the South African Police Service Veterinary Services in Potchefstroom, where she conducted animal health assessments, collected and analyzed samples, managed records, and administered treatments to horses. Currently serving as a Learner Retail Trainee Manager at NWK, she is enhancing her managerial, marketing, and customer service skills within the retail sector. Her technical competencies extend to biosecurity measures, data management, and computer literacy, complemented by excellent communication, organizational, and teamwork abilities. She has actively contributed to research, co-authoring a scientific article titled “Coxiella burnetii (Q fever) small ruminants on farms in North West Province, South Africa” (Manuscript ID: vetsci-342403), demonstrating her engagement in scholarly work. Katleho’s excellence in presentation and research has been recognized through the Onderstepoort Biological Products Animal Health Technician Award for Best Presentation at the 20th Annual SASVEPM Congress held in August 2023 at Avani Resort, Gaborone, Botswana.

Profile: ORCID

Featured Publication

Mosikidi, K. N., Mphuthi, N. M., Mangena, M. L., Lazarus, D. D., Sirdar, M., & Gcebe, N. (2025). Coxiella burnetii (Q Fever) in small ruminants on farms in North West Province, South Africa. Veterinary Sciences, 12(4), Article 315.

Cited by: 2

Alaa Hamza Abbas | Epidemiology | Best Researcher Award

Published on by Global Diseases Research

Dr. Alaa Hamza Abbas | Epidemiology | Best Researcher Award 

Lecturer | Al-Mustaqbal University | Iraq

Dr. Alaa Hamza Abbas Sultan is a distinguished academic and researcher from Iraq, currently serving as Director of the Drugs and Forensic Poisons Information Center at Diwaniyah Health. He earned his Ph.D. and M.Sc. in Pharmacology from Al-Nahrain University, following a Bachelor of Pharmacy from Mosul University. His professional journey includes roles as a pharmacist, lecturer, certified trainer, and health administrator, contributing significantly to clinical pharmacology, medical education, and healthcare development. Dr. Abbas has been actively involved in reviewing for reputable journals and has participated in numerous international conferences, both as a researcher and reviewer. His research focuses on pharmacological interventions for metabolic disorders, inflammation, and dermatological conditions, with several impactful studies exploring the therapeutic effects of natural products and pharmacological agents, especially in models of hyperglycemia, hyperlipidemia, and psoriasis. Notable publications include articles in Naunyn-Schmiedeberg’s Archives of Pharmacology, ACS Pharmacology & Translational Science, and the Journal of Taibah University Medical Sciences. Beyond research, he contributes to teaching pharmacology, histology, and medical sciences, mentoring future professionals. His scholarly presence is recognized across Google Scholar, Scopus, ORCID, and Web of Science, reflecting his integration into the global scientific community. Dr. Abbas has authored 10 publications, which collectively received 165 citations from 48 documents, showcasing the relevance of his work. His contributions have earned him an h-index of 8, reflecting both productivity and citation impact in his field

Profiles:  Scopus |  Google Scholar | ORCID

Featured Publications

1. Salman, H. R., Alzubaidy, A. A., Abbas, A. H., & Mohammad, H. A. (2024). Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. Journal of Taibah University Medical Sciences, 19(1), 35–53. Cited by: 30

2. Hayder Ridha-Salman, D. M. H. S. A. M., Al-Zubaidy, A. A., & Abbas, A. H. (2024). The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn-Schmiedeberg’s Archives of Pharmacology, 398, 1–21. Cited by: 29*

3. Ridha-Salman, H., Shihab, E. M., Hasan, H. K., Abbas, A. H., Khorsheed, S. M., & others. (2024). Mitigative effects of topical norfloxacin on an imiquimod-induced murine model of psoriasis. ACS Pharmacology & Translational Science, 7(9), 2739–2754. Cited by: 29

4. Hayder Ridha-Salman, A. H. A. Q. A. Z., & Al-Zubaidy, A. A. (2023). The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology. Cited by: 28*

5. Abbas, A. H. (2023). The attenuated effects of Epagliflozin on imiquimod-induced model of psoriasis. Latin American Journal of Pharmacy, 42(Special Issue), 362–369. Cited by: 21